World spotlights Kuwait's scientific dominance in the battle against diabetes
The Dasman Diabetes Institute (DDI) has taken a significant step forward in the global fight against diabetes, with recent joint research initiatives aimed at preventing, managing, and understanding the complications of the disease.
At the heart of these collaborations is a partnership with Sanofi, a global leader in healthcare, signed in July 2025. This partnership focuses on enhancing diabetes care in Kuwait through education programs for healthcare practitioners, the introduction of new insulin-based combination therapies minimizing the risk of hypoglycemia, and the promotion of the "My Dose Coach" app, which aids patients in managing their insulin dosages more effectively [1].
Dr. Faisal Hamed Al-Rifai, Acting Director General of the Dasman Diabetes Institute, spoke on the sidelines of the conference, emphasizing Kuwait's proactive role in global health research and the institute's commitment to scientific leadership. He highlighted the significance of the institute's involvement in the 85th Annual Conference of the American Diabetes Association, held in Chicago, USA, where DDI marked the largest participation by any Arab institution [2].
The collaborations extend beyond the partnership with Sanofi, as the Dasman team held several meetings with leading international universities and research centers during the conference. While specific details about the nature of these joint research initiatives were not disclosed, the partnership with Sanofi and the institute’s recognized leadership suggest active collaborations focusing on education, innovative therapies, and diabetes self-management technologies.
The Dasman team also presented an impressive array of research posters at the conference, showcasing their ongoing contributions to scientific advancements in the field of diabetes and its complications. However, no new details about the outcomes of these meetings or the research posters were provided.
These collaborations underscore DDI's commitment to enhancing global research partnerships and advancing scientific understanding of diabetes. By combining local knowledge with global expertise and solutions, the institute is making strides in improving diabetes prevention, management, and care on a global scale [1][2].
Sources: [1] Dasman Diabetes Institute. (2025). Sanofi and Dasman Diabetes Institute Partner to Intensify Diabetes Prevention and Care in Kuwait. Retrieved from https://www.dasman-diabetes.org/news/sanofi-and-dasman-diabetes-institute-partner-to-intensify-diabetes-prevention-and-care-in-kuwait
[2] Dasman Diabetes Institute. (2025). Dasman Diabetes Institute Makes a Mark at the 85th Annual Conference of the American Diabetes Association. Retrieved from https://www.dasman-diabetes.org/news/dasman-diabetes-institute-makes-a-mark-at-the-85th-annual-conference-of-the-american-diabetes-association
- The Dasman Diabetes Institute's joint research initiatives, such as the partnership with Sanofi, are primarily focused on understanding and managing chronic diseases like type-2 diabetes, with an emphasis on developing new medical-condition management strategies and innovative health-and-wellness solutions.
- As part of their global efforts, the Dasman Diabetes Institute is actively collaborating with leading international universities and research centers to explore and prevent the complications associated with chronic diseases such as type-2 diabetes, aiming to contribute significantly to the scientific leadership in diabetes research on a global scale.
